Stay updated on Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial

Sign up to get notified when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    1%
    Check dated 2024-12-07T21:51:31.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The website has added new features while removing detailed options for participant groups, interventions, and various data fields for downloads.
    Difference
    2%
    Check dated 2024-11-23T06:25:44.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Several key resources related to HIV and clinical trials have been removed, including links to MedlinePlus and multiple PubMed articles.
    Difference
    0.3%
    Check dated 2024-11-16T02:09:01.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, adding numerous links to clinical trial documents and PubMed articles, while removing the previous version v2.12.1.
    Difference
    3%
    Check dated 2024-11-08T19:20:10.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.0%
    Check dated 2024-11-01T11:44:45.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential improvements or features.
    Difference
    0.1%
    Check dated 2024-10-25T01:27:43.000Z thumbnail image

Stay in the know with updates to Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.